Jacqueline D Holden

Jacqueline D. Holden serves as Chief of the NICHD Contracts Management Branch, overseeing the full lifecycle of federal acquisitions supporting the National Institute of Child Health and Human Development’s research mission. In this leadership role, she ensures compliance with federal procurement regulations while strategically aligning contract vehicles with the Institute’s scientific priorities. Her portfolio encompasses complex, high-value research and development contracts, primarily focused on life sciences, engineering, and physical science investigations aimed at advancing child health, human development, and reproductive biology. She guides a team of contracting professionals in soliciting, awarding, and administering contracts that enable cutting-edge scientific inquiry across academic, nonprofit, and private-sector institutions. While no specific contractor relationships are identified in current data, Ms. Holden’s branch engages a broad spectrum of research institutions, universities, and scientific service providers with demonstrated expertise in experimental design, clinical trial support, data analytics, and laboratory instrumentation. Her team prioritizes performance-based contracting methods and values long-term vendor partnerships grounded in technical excellence, regulatory compliance, and mission alignment rather than transactional relationships. Ms. Holden’s contracting patterns reflect a strong preference for full and open competition, with 100% of awards issued under non-set-aside authorities. This indicates a strategic focus on selecting the most qualified offerors regardless of socioeconomic status, consistent with NIH’s emphasis on scientific merit and technical capability over socioeconomic preferences in research procurement. Her primary procurement focus is squarely on NAICS 541712—Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology). She routinely manages contracts for basic and translational research, laboratory services, clinical research support, bioinformatics, and scientific instrumentation development, underscoring deep expertise in the technical and regulatory demands of federally funded biomedical R&D.